Vinson & Elkins LLP advised Reata Pharmaceuticals, Inc. on the deal. Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced its public offering of 2,000,000 shares of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
